144 related articles for article (PubMed ID: 38576447)
21. In vitro and in vivo hematopoietic effect of mutant human granulocyte colony-stimulating factor.
Okabe M; Asano M; Kuga T; Komatsu Y; Yamasaki M; Yokoo Y; Itoh S; Morimoto M; Oka T
Blood; 1990 May; 75(9):1788-93. PubMed ID: 1691933
[TBL] [Abstract][Full Text] [Related]
22. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
Andrews RG; Briddell RA; Knitter GH; Opie T; Bronsden M; Myerson D; Appelbaum FR; McNiece IK
Blood; 1994 Aug; 84(3):800-10. PubMed ID: 7519077
[TBL] [Abstract][Full Text] [Related]
23. Construction of a Pichia pastoris strain efficiently producing recombinant human granulocyte-colony stimulating factor (rhG-CSF) and study of its biological activity on bone marrow cells.
Pykhtina MB; Romanov VP; Miroshnichenko SM; Beklemishev AB
Mol Biol Rep; 2020 Jan; 47(1):607-620. PubMed ID: 31713007
[TBL] [Abstract][Full Text] [Related]
24. Effects of recombinant human granulocyte colony-stimulating factor on the growth potential of two murine myeloid leukemias.
Kabaya K; Obuchi M; Kuwaki T; Shibuya K; Watanabe M; Nemoto K; Yoshida K; Kusaka M; Inoue T; Seki M
Leuk Res; 1996 Jan; 20(1):27-35. PubMed ID: 8632675
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
Sugiura M; Yamamoto K; Sawada Y; Iga T
Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
[TBL] [Abstract][Full Text] [Related]
26. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.
Ohsaka A; Kitagawa S; Sakamoto S; Miura Y; Takanashi N; Takaku F; Saito M
Blood; 1989 Dec; 74(8):2743-8. PubMed ID: 2479431
[TBL] [Abstract][Full Text] [Related]
27. Stabilization of granulocyte colony-stimulating factor and structurally analogous growth factors by anionic phospholipids.
Rourke AM; Cha Y; Collins D
Biochemistry; 1996 Sep; 35(36):11913-7. PubMed ID: 8794774
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence.
Yuo A; Kitagawa S; Ohsaka A; Ohta M; Miyazono K; Okabe T; Urabe A; Saito M; Takaku F
Blood; 1989 Nov; 74(6):2144-9. PubMed ID: 2553162
[TBL] [Abstract][Full Text] [Related]
29. Mutant protein of recombinant human granulocyte colony-stimulating factor for receptor binding assay.
Watanabe M; Fukamachi H; Uzumaki H; Kabaya K; Tsumura H; Ishikawa M; Matsuki S; Kusaka M
Anal Biochem; 1991 May; 195(1):38-44. PubMed ID: 1716070
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacological effect of recombinant human granulocyte colony-stimulating factor conjugated to poly(styrene-co-maleic acid) in rats.
Kunimasa JI; Itoga Y; Yasuhara M; Hori R; Inui KI
J Pharm Pharmacol; 1999 Jul; 51(7):777-82. PubMed ID: 10467951
[TBL] [Abstract][Full Text] [Related]
31. Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia.
Wu FP; Wang J; Wang H; Li N; Guo Y; Cheng YJ; Liu Q; Yang XR
Exp Ther Med; 2015 Mar; 9(3):761-765. PubMed ID: 25667625
[TBL] [Abstract][Full Text] [Related]
32. Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic.
Wei C; Zhang Y; Wang W; Zhang W
Cancer Manag Res; 2021; 13():3219-3225. PubMed ID: 33880064
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor.
Lee M; Aoki M; Kondo T; Kobayashi K; Okumura K; Komori K; Murohara T
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2535-41. PubMed ID: 16224058
[TBL] [Abstract][Full Text] [Related]
34. Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight.
Zhai Y; Zhao Y; Lei J; Su Z; Ma G
J Biotechnol; 2009 Jul; 142(3-4):259-66. PubMed ID: 19497340
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
Tanaka H; Tokiwa T
J Pharmacol Exp Ther; 1990 Nov; 255(2):724-9. PubMed ID: 1700818
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
Matsuzaki G; Li XY; Ohyama Y; Nomoto K
Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
[TBL] [Abstract][Full Text] [Related]
38. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice.
Uckun FM; Souza L; Waddick KG; Wick M; Song CW
Blood; 1990 Feb; 75(3):638-45. PubMed ID: 1688721
[TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of recombinant human granulocyte colony-stimulating factor (rhG-CSF) derivatives: KW-2228 and other derivatives.
Yamasaki M; Konishi N; Yamaguchi K; Itoh S; Yokoo Y
Biosci Biotechnol Biochem; 1998 Aug; 62(8):1528-34. PubMed ID: 9757559
[TBL] [Abstract][Full Text] [Related]
40. [Comparative study on the efficacy and safety between pegfilgrastim (PEG-rhG-CSF) and recombinant human granulocyte colony-stimulating factor in promoting hematopoietic recovery after allogeneic hematopoietic stem cell transplantation after hematological malignancy].
Yang F; Sun XD; Yuan L; Zhang JC; Hu JW; Liu N; Lou X; Su YF; Yu ZY; Chen JL; Li YH; Hu LD; Chen H; Jiang M
Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):831-836. PubMed ID: 29166733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
